Bis-2(5H)-furanone derivatives as new anticancer agents: Design, synthesis, biological evaluation, and mechanism studies

Chem Biol Drug Des. 2018 Jul;92(1):1232-1240. doi: 10.1111/cbdd.13183. Epub 2018 Mar 25.

Abstract

New bis-2(5H)-furanone derivatives containing a benzidine core were synthesized via a one-step transition-metal-free reaction of benzidine with 5-substituted 3,4-dihalo-2(5H)-furanones. Their antitumor activities against various tumor cells have been evaluated by MTT assay. Among them, compound 4e exhibits significant inhibitory activity against C6 glioma cells with an IC50 value of 12.1 μm and low toxicity toward HaCaT human normal cells. Studies on the antitumor mechanism reveal that cell cycle arrest at S-phase in C6 cells is induced by compound 4e. Furthermore, investigations with electronic, fluorescence emission and circular dichroism spectra show that compound 4e can significantly interact with C6-DNA. These data indicate that DNA may be one of the potential targets for bis-2(5H)-furanone derivatives as anticancer drugs.

Keywords: C6 glioma cells; DNA-binding; benzidine; bis-2(5H)-furanone derivatives; cell cycle arrest.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / metabolism
  • Antineoplastic Agents / pharmacology
  • Apoptosis / drug effects
  • Cell Cycle Checkpoints / drug effects
  • Cell Line, Tumor
  • Circular Dichroism
  • DNA / chemistry
  • DNA / metabolism
  • Drug Design*
  • Drug Screening Assays, Antitumor
  • Furans / chemistry*
  • Furans / metabolism
  • Furans / pharmacology
  • Humans
  • Nucleic Acid Conformation
  • Octanols / chemistry
  • Static Electricity
  • Structure-Activity Relationship
  • Water / chemistry

Substances

  • Antineoplastic Agents
  • Furans
  • Octanols
  • Water
  • DNA